Jin Yu

691 total citations
21 papers, 512 citations indexed

About

Jin Yu is a scholar working on Molecular Biology, Nephrology and Physiology. According to data from OpenAlex, Jin Yu has authored 21 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Nephrology and 7 papers in Physiology. Recurrent topics in Jin Yu's work include Alzheimer's disease research and treatments (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Ion Transport and Channel Regulation (3 papers). Jin Yu is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Ion Transport and Channel Regulation (3 papers). Jin Yu collaborates with scholars based in China, Hong Kong and Taiwan. Jin Yu's co-authors include Zhengzhi Wu, Zongzheng Chen, Meiqun Cao, Qiang Zeng, Min Ma, Xiuli Zhang, Yong Luo, Tingjiao Liu, Yao Lu and Wing Sum Siu and has published in prestigious journals such as Nutrients, Journal of Ethnopharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Jin Yu

20 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Yu China 10 184 152 63 58 49 21 512
Shuai Shao China 15 264 1.4× 32 0.2× 80 1.3× 44 0.8× 74 1.5× 20 513
Zhiping Miao China 13 482 2.6× 42 0.3× 42 0.7× 79 1.4× 45 0.9× 28 726
Xiangyi Chen China 11 177 1.0× 33 0.2× 31 0.5× 46 0.8× 88 1.8× 24 418
Peimin Wang China 14 267 1.5× 49 0.3× 38 0.6× 37 0.6× 81 1.7× 27 541
Shuai Huang China 17 422 2.3× 48 0.3× 54 0.9× 62 1.1× 43 0.9× 38 802
Maolin He China 13 182 1.0× 48 0.3× 45 0.7× 26 0.4× 29 0.6× 34 515
Qiang Xue China 17 331 1.8× 24 0.2× 29 0.5× 41 0.7× 39 0.8× 43 646
Lina Zhou China 17 261 1.4× 33 0.2× 41 0.7× 39 0.7× 41 0.8× 49 596
Meng Gao China 13 214 1.2× 37 0.2× 26 0.4× 33 0.6× 24 0.5× 31 486

Countries citing papers authored by Jin Yu

Since Specialization
Citations

This map shows the geographic impact of Jin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Yu more than expected).

Fields of papers citing papers by Jin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Yu. The network helps show where Jin Yu may publish in the future.

Co-authorship network of co-authors of Jin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Yu. A scholar is included among the top collaborators of Jin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Yu. Jin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ding, Dongmei Xi, Yanming Wang, et al.. (2025). Apigenin prevents hypertensive vascular remodeling by regulating the TP53 pathway. International Immunopharmacology. 157. 114706–114706.
2.
Yu, Jin, et al.. (2024). Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives. Molecular Therapy — Nucleic Acids. 35(3). 102281–102281. 6 indexed citations
3.
Zheng, Jiaojiao, Feng Wan, Shaojun Liu, et al.. (2023). The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition. International Urology and Nephrology. 55(8). 2119–2129. 2 indexed citations
5.
Ding, Yin, et al.. (2022). Tetrandrine Attenuates Podocyte Injury by Inhibiting TRPC6-Mediated RhoA/ROCK1 Pathway. Analytical Cellular Pathology. 2022. 1–8. 7 indexed citations
6.
Yu, Jin, et al.. (2022). Network Pharmacology and In Vivo Experimental Validation to Uncover the Renoprotective Mechanisms of Fangji Huangqi Decoction on Nephrotic Syndrome. Evidence-based Complementary and Alternative Medicine. 2022. 1–17. 7 indexed citations
7.
Ding, Yin, et al.. (2021). Tetrandrine alleviates podocyte injury via calcium-dependent calpain-1 signaling blockade. BMC Complementary Medicine and Therapies. 21(1). 296–296. 12 indexed citations
8.
Yu, Jin, et al.. (2020). <p>Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling</p>. Drug Design Development and Therapy. Volume 14. 361–370. 16 indexed citations
10.
Li, Yinghong, Jin Yu, Xusheng Wang, et al.. (2020). Neuroprotective Effect of Fructus broussonetiae on APP/PS1 Mice via Upregulation of AKT/β-Catenin Signaling. Chinese Journal of Integrative Medicine. 27(2). 115–124. 8 indexed citations
12.
Ye, Cong, Youping Wang, Zongzheng Chen, et al.. (2020). Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review. Micromachines. 11(4). 381–381. 92 indexed citations
13.
Zeng, Qiang, Longfei Li, Jin Yu, et al.. (2019). A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2019. 1–12. 29 indexed citations
14.
Zeng, Qiang, Longfei Li, Wing Sum Siu, et al.. (2019). A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease. Biomedicine & Pharmacotherapy. 120. 109370–109370. 73 indexed citations
15.
Zeng, Qiang, Wing Sum Siu, Limin Li, et al.. (2019). Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine. Experimental Gerontology. 119. 100–110. 49 indexed citations
16.
Deng, Jiu, Xiuli Zhang, Zongzheng Chen, et al.. (2019). A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction. Biomicrofluidics. 13(2). 24101–24101. 54 indexed citations
17.
Wang, Xusheng, Haiyan Chen, Xiaowei Zeng, et al.. (2018). Efficient lung cancer-targeted drug delivery via a nanoparticle/MSC system. Acta Pharmaceutica Sinica B. 9(1). 167–176. 102 indexed citations
18.
Li, Yinghong, Xiaolin Chen, Jin Yu, et al.. (2017). Neuroprotective effect of the Chinese medicine Tiantai No. 1 and its molecular mechanism in the senescence-accelerated mouse prone 8. Neural Regeneration Research. 12(2). 301–301. 2 indexed citations
19.
Wang, Yuhui, et al.. (2015). Association between tongue coating thickness and clinical characteristics among idiopathic membranous nephropathy patients. Journal of Ethnopharmacology. 171. 125–130. 14 indexed citations
20.
Li, Yinghong, Zhengzhi Wu, Jin Yu, et al.. (2012). Analysis of hippocampal gene expression profile of Alzheimer's disease model rats using genome chip bioinformatics.. PubMed. 7(5). 332–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026